Sheller, P.C. Attorney Brian J. McCormick comments on whether recent verdicts of $1.5+ billion will influence Johnson and Johnson policy and ultimately affect consumers.

BEERSE, Belgium, April 19, 2012 /PRNewswire/ -- Today sees the launch of Janssen Therapeutics EMEA, a division of Janssen Pharmaceutica NV, dedicated to bringing the investigational

TITUSVILLE, N.J., April 12, 2012 /PRNewswire/ -- Janssen Therapeutics, Division of Janssen Products, LP, is supporting education for lesbian, gay, bisexual and transgender (LGBT) students through

OXFORD, England, March 21, 2012 /PRNewswire/ -- Fintan Walton talks exclusively to Johnson & Johnson (J&J) and GlaxoSmithKline (GSK) about their participation in

SAN DIEGO, Jan.